Plastic and Reconstructive Surgery, Global Open (Apr 2022)

Use of Needle Localization in the Surgical Management of Non-seroma, Mass-forming BIA-ALCL

  • David H. Kim, MD,
  • Theresa K. Webster, BS,
  • Joseph G. Bartolacci, PhD,
  • Sthefano Araya, MD,
  • Juliet Panichella, BS,
  • Sameer A. Patel, MD

DOI
https://doi.org/10.1097/GOX.0000000000004286
Journal volume & issue
Vol. 10, no. 4
p. e4286

Abstract

Read online

Summary:. Outcomes related to the treatment of breast implant-associated anaplastic large cell lymphoma, a rare extranodal T-cell lymphoma associated with textured breast implants, are largely dependent on the successful resection to negative margins via en bloc capsulectomy and resection of any associated masses. To date, the use of needle localization, a common technique used in breast surgery, to assist in the complete removal of breast implant-associated anaplastic large cell lymphoma has not been described. We present the case report of a 66-year-old woman, with a previous medical history of left-sided invasive ductal carcinoma, who presented 7 years after textured breast implant placement with a left-sided mass without peri-implant seroma. Biopsy demonstrated breast implant-associated anaplastic large cell lymphoma and the associated breast mass extended beyond the capsule borders. The present report describes the novel use of needle localization in this patient to facilitate the complete removal of the malignancy-associated mass with maximal preservation of the overlying soft tissue envelope.